The cardiac drug, Crestor, is said to be one of the biggest launches for USFDA this year and the market size for the drug is about USD 3 billion, reports Ekta Batra of CNBC-TV18. The drug goes off patent tomorrow in the US.
first published: Jul 8, 2016 11:53 am
A collection of the most-viewed Moneycontrol videos.
Sensex, Nifty Retreat After Hitting Fresh Highs As Rupee Drops To Record Low| Closing Bell Live
Will Solid Q2 GDP Set The Ball Rolling For Nifty Bulls To Cross 26,300 Decisively?|Opening Bell Live
SOBO to Bandra: Why Only South Mumbai Residents Call Bandra a Downgrade | The Tenant
Live: Nifty registers third straight week of gains, up 2% in November | Closing Bell
